comparemela.com

Latest Breaking News On - Fundamental investments - Page 3 : comparemela.com

Insider Selling: Allogene Therapeutics, Inc. (NASDAQ:ALLO) Director Sells 11,200 Shares of Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) Director Franz B. Humer sold 11,200 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $2.34, for a total value of $26,208.00. Following the completion of the sale, the director now owns 255,253 […]

Canada
Franzb-humer
Piper-sandler
Canada-life-assurance
Pricet-rowe-associates-inc
Allogene-therapeutics-company-profile
Nasdaq
Allogene-therapeutics-inc
Susquehanna-fundamental-investments
Jpmorgan-chase-co
Securities-exchange-commission
Headlands-technologies

Rackspace Technology, Inc. (NASDAQ:RXT) Receives Average Rating of "Hold" from Brokerages

Shares of Rackspace Technology, Inc. (NASDAQ:RXT – Get Free Report) have received a consensus rating of “Hold” from the eight research firms that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have issued a buy recommendation […]

Canada
Raymond-james
Raymond-james-associates
Tower-research-capital
Rackspace-technology-inc
Analyst-recommendations-for-rackspace-technology
Multicloud-services
Rackspace-technology-stock-performance
Rackspace-technology
Royal-bank
Susquehanna-fundamental-investments
Insider-transactions-at-rackspace-technology

CytomX Therapeutics (NASDAQ:CTMX) Upgraded at Piper Sandler

Piper Sandler upgraded shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) from a neutral rating to an overweight rating in a report published on Tuesday morning, MarketBeat.com reports. Piper Sandler currently has $3.50 price objective on the biotechnology company’s stock, up from their prior price objective of $2.25. A number of other research firms have […]

Piper-sandler
Seana-mccarthy
Jpmorgan-chase-co
Congress-park-capital
Alphamark-advisors
Jefferies-financial-group
Acadian-asset-management
Sg-americas-securities
Susquehanna-fundamental-investments
Cytomx-therapeutics-inc
Cytomx-therapeutics-company-profile
Securities-exchange-commission

CytomX Therapeutics (NASDAQ:CTMX) Stock Rating Upgraded by Piper Sandler

Piper Sandler upgraded shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) from a neutral rating to an overweight rating in a research note published on Tuesday, Marketbeat Ratings reports. The brokerage currently has $3.50 price target on the biotechnology company’s stock, up from their prior price target of $2.25. Several other equities analysts have also […]

Seana-mccarthy
Piper-sandler
Jpmorgan-chase-co
Congress-park-capital
Jefferies-financial-group
Sg-americas-securities
Acadian-asset-management
Susquehanna-fundamental-investments
Cytomx-therapeutics-inc
York-mellon-corp
Securities-exchange-commission
Cytomx-therapeutics-company-profile

Heron Therapeutics (NASDAQ:HRTX) Hits New 52-Week High at $3.65

Heron Therapeutics (NASDAQ:HRTX) Hits New 52-Week High at $3.65
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Susquehanna-fundamental-investments
Victory-capital-management-inc
Nasdaq
Headlands-technologies
Heron-therapeutics-inc
Needham-company
Heron-therapeutics
Get-free-report
One-financial
Fundamental-investments
Capital-management
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.